FGFR3 Status Associated With Differential Sensitivity to Platinum-Based Chemotherapy in Urothelial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Fibroblast Growth Factor Receptor 3 Alteration Status Is Associated With Differential Sensitivity to Platinum-Based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma
Eur Urol 2020 Dec 01;78(6)907-915, MY Teo, JM Mota, KA Whiting, HA Li, SA Funt, CH Lee, DB Solit, H Al-Ahmadie, MI Milowsky, AV Balar, E Pietzak, G Dalbagni, BH Bochner, I Ostrovnaya, DF Bajorin, JE Rosenberg, G IyerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.